Cargando…

An Inverse Dose Optimization Algorithm for Three-Dimensional Brachytherapy

PURPOSE: To investigate an implementation method and the results of an inverse dose optimization algorithm, Gradient Based Planning Optimization (GBPO), for three-dimensional brachytherapy. METHODS: The GBPO used a quadratic objective function, and a dwell time modulation item was added to the objec...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Xianliang, Wang, Pei, Tang, Bin, Kang, Shengwei, Hou, Qing, Wu, Zhangwen, Gou, Chengjun, Li, Lintao, Orlandini, Lucia, Lang, Jinyi, Li, Jie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7606999/
https://www.ncbi.nlm.nih.gov/pubmed/33194640
http://dx.doi.org/10.3389/fonc.2020.564580
_version_ 1783604552646262784
author Wang, Xianliang
Wang, Pei
Tang, Bin
Kang, Shengwei
Hou, Qing
Wu, Zhangwen
Gou, Chengjun
Li, Lintao
Orlandini, Lucia
Lang, Jinyi
Li, Jie
author_facet Wang, Xianliang
Wang, Pei
Tang, Bin
Kang, Shengwei
Hou, Qing
Wu, Zhangwen
Gou, Chengjun
Li, Lintao
Orlandini, Lucia
Lang, Jinyi
Li, Jie
author_sort Wang, Xianliang
collection PubMed
description PURPOSE: To investigate an implementation method and the results of an inverse dose optimization algorithm, Gradient Based Planning Optimization (GBPO), for three-dimensional brachytherapy. METHODS: The GBPO used a quadratic objective function, and a dwell time modulation item was added to the objective function to restrict the dwell time variance. We retrospectively studied 4 cervical cancer patients using different applicators and 15 cervical cancer patients using the Fletcher applicator. We assessed the plan quality of GBPO by isodose lines for the patients using different applicators. For the 15 patients using the Fletcher applicator, we utilized dose-volume histogram (DVH) parameters of HR-CTV (D(100%), V(150%)) and organs at risk (OARs) (D(0.1cc), D(1cc), D(2cc)) to evaluate the difference between the GBPO plans and the IPSA (Inverse Planning Simulated Annealing) plans, as well as the GBPO plans and the Graphic plans. RESULTS: For the 4 patients using different applicators, the dose distributions are conformable. For the 15 patients using the Fletcher applicator, when the dwell time modulation factor (DTMF) is less than 20, the dwell time deviation reduces quickly; however, after the DTMF increased to 100, the dwell time deviation has no remarkable change. The difference in dosimetric parameters between the GBPO plans and the IPSA plans is not statistically significant (P>0.05). The GBPO plans have a higher D(100%) (3.57 ± 0.36, 3.38 ± 0.34; P<0.01) and a lower V(150%) (55.73 ± 4.06, 57.75 ± 3.79; P<0.01) than those of the Graphic plans. The differences in other DVH parameters are negligible between the GBPO plans and the Graphic plans. CONCLUSIONS: The GBPO plans have a comparable quality as the IPSA plans and the Graphic plans for the studied cervical cancer cases. The GBPO algorithm could be integrated into a three-dimensional brachytherapy treatment planning system after studying more sites.
format Online
Article
Text
id pubmed-7606999
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-76069992020-11-13 An Inverse Dose Optimization Algorithm for Three-Dimensional Brachytherapy Wang, Xianliang Wang, Pei Tang, Bin Kang, Shengwei Hou, Qing Wu, Zhangwen Gou, Chengjun Li, Lintao Orlandini, Lucia Lang, Jinyi Li, Jie Front Oncol Oncology PURPOSE: To investigate an implementation method and the results of an inverse dose optimization algorithm, Gradient Based Planning Optimization (GBPO), for three-dimensional brachytherapy. METHODS: The GBPO used a quadratic objective function, and a dwell time modulation item was added to the objective function to restrict the dwell time variance. We retrospectively studied 4 cervical cancer patients using different applicators and 15 cervical cancer patients using the Fletcher applicator. We assessed the plan quality of GBPO by isodose lines for the patients using different applicators. For the 15 patients using the Fletcher applicator, we utilized dose-volume histogram (DVH) parameters of HR-CTV (D(100%), V(150%)) and organs at risk (OARs) (D(0.1cc), D(1cc), D(2cc)) to evaluate the difference between the GBPO plans and the IPSA (Inverse Planning Simulated Annealing) plans, as well as the GBPO plans and the Graphic plans. RESULTS: For the 4 patients using different applicators, the dose distributions are conformable. For the 15 patients using the Fletcher applicator, when the dwell time modulation factor (DTMF) is less than 20, the dwell time deviation reduces quickly; however, after the DTMF increased to 100, the dwell time deviation has no remarkable change. The difference in dosimetric parameters between the GBPO plans and the IPSA plans is not statistically significant (P>0.05). The GBPO plans have a higher D(100%) (3.57 ± 0.36, 3.38 ± 0.34; P<0.01) and a lower V(150%) (55.73 ± 4.06, 57.75 ± 3.79; P<0.01) than those of the Graphic plans. The differences in other DVH parameters are negligible between the GBPO plans and the Graphic plans. CONCLUSIONS: The GBPO plans have a comparable quality as the IPSA plans and the Graphic plans for the studied cervical cancer cases. The GBPO algorithm could be integrated into a three-dimensional brachytherapy treatment planning system after studying more sites. Frontiers Media S.A. 2020-10-20 /pmc/articles/PMC7606999/ /pubmed/33194640 http://dx.doi.org/10.3389/fonc.2020.564580 Text en Copyright © 2020 Wang, Wang, Tang, Kang, Hou, Wu, Gou, Li, Orlandini, Lang and Li http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Oncology
Wang, Xianliang
Wang, Pei
Tang, Bin
Kang, Shengwei
Hou, Qing
Wu, Zhangwen
Gou, Chengjun
Li, Lintao
Orlandini, Lucia
Lang, Jinyi
Li, Jie
An Inverse Dose Optimization Algorithm for Three-Dimensional Brachytherapy
title An Inverse Dose Optimization Algorithm for Three-Dimensional Brachytherapy
title_full An Inverse Dose Optimization Algorithm for Three-Dimensional Brachytherapy
title_fullStr An Inverse Dose Optimization Algorithm for Three-Dimensional Brachytherapy
title_full_unstemmed An Inverse Dose Optimization Algorithm for Three-Dimensional Brachytherapy
title_short An Inverse Dose Optimization Algorithm for Three-Dimensional Brachytherapy
title_sort inverse dose optimization algorithm for three-dimensional brachytherapy
topic Oncology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7606999/
https://www.ncbi.nlm.nih.gov/pubmed/33194640
http://dx.doi.org/10.3389/fonc.2020.564580
work_keys_str_mv AT wangxianliang aninversedoseoptimizationalgorithmforthreedimensionalbrachytherapy
AT wangpei aninversedoseoptimizationalgorithmforthreedimensionalbrachytherapy
AT tangbin aninversedoseoptimizationalgorithmforthreedimensionalbrachytherapy
AT kangshengwei aninversedoseoptimizationalgorithmforthreedimensionalbrachytherapy
AT houqing aninversedoseoptimizationalgorithmforthreedimensionalbrachytherapy
AT wuzhangwen aninversedoseoptimizationalgorithmforthreedimensionalbrachytherapy
AT gouchengjun aninversedoseoptimizationalgorithmforthreedimensionalbrachytherapy
AT lilintao aninversedoseoptimizationalgorithmforthreedimensionalbrachytherapy
AT orlandinilucia aninversedoseoptimizationalgorithmforthreedimensionalbrachytherapy
AT langjinyi aninversedoseoptimizationalgorithmforthreedimensionalbrachytherapy
AT lijie aninversedoseoptimizationalgorithmforthreedimensionalbrachytherapy
AT wangxianliang inversedoseoptimizationalgorithmforthreedimensionalbrachytherapy
AT wangpei inversedoseoptimizationalgorithmforthreedimensionalbrachytherapy
AT tangbin inversedoseoptimizationalgorithmforthreedimensionalbrachytherapy
AT kangshengwei inversedoseoptimizationalgorithmforthreedimensionalbrachytherapy
AT houqing inversedoseoptimizationalgorithmforthreedimensionalbrachytherapy
AT wuzhangwen inversedoseoptimizationalgorithmforthreedimensionalbrachytherapy
AT gouchengjun inversedoseoptimizationalgorithmforthreedimensionalbrachytherapy
AT lilintao inversedoseoptimizationalgorithmforthreedimensionalbrachytherapy
AT orlandinilucia inversedoseoptimizationalgorithmforthreedimensionalbrachytherapy
AT langjinyi inversedoseoptimizationalgorithmforthreedimensionalbrachytherapy
AT lijie inversedoseoptimizationalgorithmforthreedimensionalbrachytherapy